نتایج جستجو برای: p vivax

تعداد نتایج: 1272557  

Journal: :Infection and immunity 2013
Diego A Espinosa Anjali Yadava Evelina Angov Paul L Maurizio Christian F Ockenhouse Fidel Zavala

The development of vaccine candidates against Plasmodium vivax-the most geographically widespread human malaria species-is challenged by technical difficulties, such as the lack of in vitro culture systems and availability of animal models. Chimeric rodent Plasmodium parasites are safe and useful tools for the preclinical evaluation of new vaccine formulations. We report the successful developm...

2013
Ana C. Bahia José Henrique M. Oliveira Marina S. Kubota Helena R. C. Araújo José B. P. Lima Claudia Maria Ríos-Velásquez Marcus Vinícius G. Lacerda Pedro L. Oliveira Yara M. Traub-Csekö Paulo F. P. Pimenta

Malaria affects millions of people worldwide and hundreds of thousands of people each year in Brazil. The mosquito Anopheles aquasalis is an important vector of Plasmodium vivax, the main human malaria parasite in the Americas. Reactive oxygen species (ROS) have been shown to have a role in insect innate immune responses as a potent pathogen-killing agent. We investigated the mechanisms of free...

2014
Nicholas M Douglas Gysje J Pontororing Daniel A Lampah Tsin W Yeo Enny Kenangalem Jeanne Rini Poespoprodjo Anna P Ralph Michael J Bangs Paulus Sugiarto Nicholas M Anstey Ric N Price

BACKGROUND Plasmodium vivax causes almost half of all malaria cases in Asia and is recognised as a significant cause of morbidity. In recent years it has been associated with severe and fatal disease. The extent to which P. vivax contributes to death is not known. METHODS To define the epidemiology of mortality attributable to vivax malaria in southern Papua, Indonesia, a retrospective clinic...

2014
Constanza Martinez-Valdebenito Mario Calvo Cecilia Vial Rita Mansilla Claudia Marco R. Eduardo Palma Pablo A. Vial Francisca Valdivieso Gregory Mertz Marcela Ferrés

Numerous studies have indicated a strong association between amplification of the multidrug resistance-1 gene and in vivo and in vitro mefloquine resistance of Plasmodium falciparum. Although falciparum infection usually is not treated with mefloquine, incorrect diagnosis, high frequency of undetected mixed infections, or relapses of P. vivax infection triggered by P. falciparum infections expo...

Journal: :The American journal of tropical medicine and hygiene 2005
D Gray Heppner Douglas S Walsh Nichapat Uthaimongkol Douglas B Tang Somchit Tulyayon Barnyen Permpanich Theera Wimonwattrawatee Niphon Chuanak Anintita Laoboonchai Prasit Sookto Thomas G Brewer Philip McDaniel Chirapa Eamsila Kosol Yongvanitchit Kathleen Uhl Dennis E Kyle Lisa W Keep Robert E Miller Chansuda Wongsrichanalai

We assessed the prophylactic efficacy of azithromycin (250 mg/day) against malaria in 276 adults in western Thailand in a randomized, double-blind, placebo-controlled trial. After antimalarial suppressive treatment, volunteers were randomized in a 2:1 ratio to either the azithromycin or placebo, respectively. Study medication was given for an average of 74 days. The azithromycin group (n = 179)...

2011
Daniel A. Lampah Tsin W. Yeo Setiawan O. Hardianto Emiliana Tjitra Enny Kenangalem Paulus Sugiarto Ric N. Price Nicholas M. Anstey

BACKGROUND Coma complicates Plasmodium falciparum infection but is uncommonly associated with P. vivax. Most series of vivax coma have been retrospective and have not utilized molecular methods to exclude mixed infections with P. falciparum. METHODS We prospectively enrolled patients hospitalized in Timika, Indonesia, with a Glasgow Coma Score (GCS) ≤10 and P. vivax monoinfection on initial m...

Journal: :Journal of vector borne diseases 2015
Shubhanker Mitra Kpp Abhilash Shalabh Arora Angel Miraclin

BACKGROUND & OBJECTIVES Traditionally, Plasmodium falciparum has been attributed to cause severe malaria, whereas P. vivax is considered to cause "benign" tertian malaria. Recently, there has been an increasing body of evidence challenging this conviction. However, the spectrum and degree of severity of the disease caused by P. vivax, as per World Health Organization (2012) remains unclear. Thu...

2013
Abbas SHAHBAZI Pegah FARHADI Masoud YERIAN Ahad BAZMANI Sara KHADEM NAKHJIRI Arash RASOULI Ahmad RAEISI

BACKGROUND Plasmodium vivax is the most widespread species of Plasmodium in humans and causing about 80 million clinical cases annually. This study was undertaken to detect P. vivax in asymptomatic treated vivax malaria patients to trace latent/sub-patent malaria infection. METHOD The venous blood of all detected cases with P. vivax in Bashagard, Minab and Roodan Districts in Hormozgan Provin...

Journal: :The Southeast Asian journal of tropical medicine and public health 1992
P M Graves R Boreham G Robert L Fray L J Xu Y M Huang W Relf A Saul C Kidson

Parasite extracts of Plasmodium falciparum and P. chabaudi and three synthetic peptides from the P. falciparum MSA2 merozoite antigen were tested for suitability as antigens in an antibody detection ELISA using sera from malaria patients in Brisbane. The P. chabaudi extract was superior to P. falciparum extract for detecting P. vivax cases, while for P. falciparum cases the two parasite extract...

2013
Rodrigo M. Souza Ricardo Ataíde Jamille G. Dombrowski Vanessa Ippólito Elizabeth H. Aitken Suiane N. Valle José M. Álvarez Sabrina Epiphânio Claudio R. F. Marinho

Histological evidence of Plasmodium in the placenta is indicative of placental malaria, a condition associated with severe outcomes for mother and child. Histological lesions found in placentas from Plasmodium-exposed women include syncytial knotting, syncytial rupture, thickening of the placental barrier, necrosis of villous tissue and intervillositis. These histological changes have been asso...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید